- Home
- VRXA vs EPM Comparison
VRXA vs EPM Comparison
Compare VRXA & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRXA | EPM |
|---|---|---|
| Founded | 2021 | 2003 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.4M | 143.0M |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VRXA | EPM |
|---|---|---|
| Price | $1.15 | $3.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 278.2K | 271.3K |
| Earning Date | N/A | 11-10-2026 |
| Dividend Yield | N/A | ★ 12.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,229,621.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $3.19 |
| 52 Week High | $4.50 | $4.99 |
Technical Indicators
Market Signals| Indicator | VRXA | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 49.44 |
| Support Level | $1.04 | $3.46 |
| Resistance Level | $1.41 | $3.79 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 45.00 | 25.64 |
Price Performance
Historical ComparisonAbout VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.